{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:54Z","timestamp":1793946474908,"version":"4.8.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP41415\/2021"],"award-info":[{"award-number":["BT\/INF\/22\/SP41415\/2021"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbagen.2026.130937","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:51:18Z","timestamp":1774338678000},"page":"130937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolite profiling identifies upregulation of specific glycerophospholipids and sphingolipids in imatinib-resistant cell lines"],"prefix":"10.1016","volume":"1870","author":[{"given":"Divya","family":"Presingu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Charitha","family":"Mullaguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayasarathy","family":"Ketavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramunaidu","family":"Addipilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama Krishna","family":"Kancha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeshwar Reddy","family":"Thota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.bbagen.2026.130937_bb0005","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130937_bb0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bbagen.2026.130937_bb0015","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.3390\/cancers12113443","article-title":"Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in chronic myeloid leukemia","volume":"12","author":"Mostazo","year":"2020","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.bbagen.2026.130937_bb0020","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1007\/s00216-015-8633-2","article-title":"Optimizing the lipidomics workflow for clinical studies\u2014practical considerations","volume":"407","author":"Hy\u00f6tyl\u00e4inen","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130937_bb0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/metabo15060376","article-title":"Metabolomic profiling and bioanalysis of chronic myeloid leukemia: identifying biomarkers for treatment response and disease monitoring","volume":"15","author":"Say\u0131n","year":"2025","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130937_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041180","article-title":"Metabolomic analysis of patients with chronic myeloid leukemia and cardiovascular adverse events after treatment with tyrosine kinase inhibitors","volume":"9","author":"Caocci","year":"2020","journal-title":"J. Clin. Med."},{"issue":"13","key":"10.1016\/j.bbagen.2026.130937_bb0035","article-title":"Bioactive lipids as chronic myeloid leukemia\u2019s potential biomarkers for disease progression and response to tyrosine kinase inhibitors","author":"de Almeida","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130937_bb0040","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/acs.jproteome.9b00028","article-title":"Multiomic profiling of tyrosine kinase inhibitor-resistant K562 cells suggests metabolic reprogramming to promote cell survival","volume":"18","author":"Noel","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbagen.2026.130937_bb0045","article-title":"ZFAS1\/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming","volume":"15","author":"Yang","year":"2025","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130937_bb0050","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"issue":"534","key":"10.1016\/j.bbagen.2026.130937_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbrc.2020.11.059","article-title":"Analysis of cellular models of clonal evolution reveals co-evolution of imatinib and HSP90 inhibitor resistances","author":"Arolla","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130937_bb0060","doi-asserted-by":"crossref","first-page":"21809","DOI":"10.1038\/s41598-023-48970-0","article-title":"Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy","volume":"13","author":"Bolkun","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130937_bb0065","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.bbamem.2006.06.016","article-title":"Sphingolipid players in the leukemia arena","volume":"1758","author":"Ricci","year":"2006","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembr."},{"issue":"21","key":"10.1016\/j.bbagen.2026.130937_bb0070","doi-asserted-by":"crossref","first-page":"12745","DOI":"10.3390\/ijms232112745","article-title":"Advancements on the multifaceted roles of sphingolipids in hematological malignancies","volume":"23","author":"Raza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130937_bb0075","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbalip.2007.09.005","article-title":"Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells","volume":"1771","author":"Gouaz\u00e9-Andersson","year":"2007","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130937_bb0080","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/bjc.2015.86","article-title":"Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours","volume":"112","author":"Beloueche-Babari","year":"2015","journal-title":"Br. J. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:34:19Z","timestamp":1793943259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0304416526000371"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130937","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolite profiling identifies upregulation of specific glycerophospholipids and sphingolipids in imatinib-resistant cell lines","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130937"}}